Related references
Note: Only part of the references are listed.Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter
P. Giorgi Rossi et al.
BRITISH JOURNAL OF CANCER (2015)
Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: A systematic review and meta-analysis of randomised trials
F. Verdoodt et al.
EUROPEAN JOURNAL OF CANCER (2015)
Increasing participation in cervical cancer screening: Offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial
Gudrun Broberg et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Are 20 human papillomavirus types causing cervical cancer?
Marc Arbyn et al.
JOURNAL OF PATHOLOGY (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
Marc Arbyn et al.
LANCET ONCOLOGY (2014)
Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening
Matejka Rebolj et al.
PLOS ONE (2014)
Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women
Remko P. Bosgraaf et al.
PREVENTIVE MEDICINE (2014)
Mortality audit of the Finnish cervical cancer screening program
Stefan Lonnberg et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 Norwegian women
Bo T. Hansen et al.
BMC PUBLIC HEALTH (2011)
The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)
P. Giorgi Rossi et al.
BRITISH JOURNAL OF CANCER (2011)
HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial
A. Szarewski et al.
BRITISH JOURNAL OF CANCER (2011)
Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings
Laia Bruni et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Trends of cervical cancer mortality in the member states of the European Union
Marc Arbyn et al.
EUROPEAN JOURNAL OF CANCER (2009)
Human Papillomavirus Genotype Specificity of Hybrid Capture 2 Low-Risk Probe Cocktail
Mario Poljak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
Peter Sasieni et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Human papillomavirus genotype specificity of Hybrid Capture 2
Philip E. Castle et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Screening-preventable cervical cancer risks:: Evidence from a nationwide audit in Sweden
Bengt Andrae et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer:: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program
JF Nygård et al.
CANCER CAUSES & CONTROL (2005)
The cervical cancer screening programme in Norway 1992-2000: changes in Pap smear coverage and incidence of cervical cancer
JF Nygard et al.
JOURNAL OF MEDICAL SCREENING (2002)
Reasons women do not attend screening for cervical cancer:: A population-based study in Sweden
S Eaker et al.
PREVENTIVE MEDICINE (2001)
Share Paper
